Industry backs biocatalysis for greener manufacturing

Professor Nick Turner’s EU funded project "Chemical Manufacturing Methods for the 21st Century" (CHEM21) has been reported in Nature Biochemistry's February 2013 News section.

Professor Nick Turner’s EU funded project "Chemical Manufacturing Methods for the 21st Century" (CHEM21) has been reported in Nature Biochemistry's February 2013 News section. The article focuses on the project’s aim to investigate alternative catalysts, including enzymes, and other green technologies that can be used to make the manufacture of pharmaceuticals less harmful. The CHEM21 project led by the School of Chemistry at the University of Manchester brings together six pharmaceutical companies, five small to medium-sized enterprises (SMEs) and 13 universities across Europe. Green processing not only has environmental benefits, but can also reduce the manufacturing costs. Prof Nick Turner notes that for the companies signed up to CHEM21, "Sustainability is very important to these companies".

▲ Up to the top